Development of tolerance upon repeated administration with the GABA_B receptor positive allosteric modulator, COR659, on alcohol drinking in rodents

References

• Orrù A, Lai P, Lobina C, Maccioni P, Piras P, Scanu L, Froestl W, Gessa GL, Carai MA, Colombo G. Reducing effect of the positive allosteric modulators of the GABAB receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. Eur J Pharmacol. 2005;525:105–11. doi:10.1016/j.ejphar.2005.10.005.
   PubMed Web of Science ®Google Scholar
• Loi B, Maccioni P, Lobina C, Carai MA, Gessa GL, Thomas AW, Malherbe P, Colombo G. Reduction of alcohol intake by the positive allosteric modulator of the GABAB receptor, rac-BHFF, in alcohol-preferring rats. Alcohol. 2013;47:69–73. doi:10.1016/j.alcohol.2012.11.002.
   PubMed Web of Science ®Google Scholar
• Hwa LS, Kalinichev M, Haddouk H, Poli S, Miczek KA. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Psychopharmacology (Berl). 2014;231:333–43. doi:10.1007/s00213-013-3245-z.
   PubMed Web of Science ®Google Scholar
• Ferlenghi F, Maccioni P, Mugnaini C, Brizzi A, Fara F, Mostallino R, Castelli MP, Colombo G, Mor M, Vacondio F, et al. The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives. Eur J Pharm Sci. 2020;155:105544. doi:10.1016/j.ejps.2020.105544.
   PubMed Web of Science ®Google Scholar
• Vengeliene V, Takahashi TT, Dravolina OA, Belozertseva I, Zvartau E, Bespalov AY, Spanagel R. Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction. Psychopharmacology (Berl). 2018;235:1955–65. doi:10.1007/s00213-018-4893-9.
   PubMed Web of Science ®Google Scholar
• Linsenbardt DN, Boehm SL,s2nd. Alterations in the rate of binge ethanol consumption: implications for preclinical studies in mice. Addict Biol. 2014;19:812–25. doi:10.1111/adb.12052.
   PubMed Web of Science ®Google Scholar
• Colombo G, Lobina C, Maccioni P, Carai MA, Lorrai I, Zaru A, Contini A, Mugnaini C, Corelli F, Gessa GL. Anxiety-like behaviors at the end of the nocturnal period in sP rats with a “history” of unpredictable, limited access to alcohol. Alcohol. 2015;49:707–12.
   PubMed Web of Science ®Google Scholar
• de Miguel E, Vekovischeva O, Kuokkanen K, Vesajoki M, Paasikoski N, Kaskinoro J, Myllymaki M, Lainiola M, Janhunen SK, Hyytia P, et al. GABAB receptor positive allosteric modulators with different efficacies affect neuroadaptation to and self-administration of alcohol and cocaine. Addict Biol. 2019;24:1191–203. doi:10.1111/adb.12688.
   PubMed Web of Science ®Google Scholar
• Lorrai I, Shankula C, Gaytan JM, Kawamura T, Maccioni P, Mugnaini C, Corelli F, Gessa GL, Sanna PP, Colombo G. Reducing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on binge-like alcohol drinking in male mice and rats. Psychopharmacology (Berl). 2022;239:201–13. doi:10.1007/s00213-021-06022-3.
   PubMed Web of Science ®Google Scholar
• Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, Lawrence AJ. The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology. 2006;50:632–39. doi:10.1016/j.neuropharm.2005.11.011.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Pes D, Orru A, Froestl W, Gessa GL, Carai MA, Colombo G. Reducing effect of the positive allosteric modulator of the GABAB receptor, GS39,783, on alcohol self-administration in alcohol-preferring rats. Psychopharmacology (Berl). 2007;193:171–78. doi:10.1007/s00213-007-0776-1.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Fantini N, Froestl W, Carai MA, Gessa GL, Colombo G. Specific reduction of alcohol’s motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783–comparison with the effect of the GABAB receptor direct agonist, baclofen. Alcohol Clin Exp Res. 2008;32:1558–64. doi:10.1111/j.1530-0277.2008.00725.x.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Thomas AW, Carai MA, Gessa GL, Malherbe P, Colombo G. The positive allosteric modulator of the GABAB receptor, rac-BHFF, suppresses alcohol self-administration. Drug Alcohol Depend. 2010;109:96–103. doi:10.1016/j.drugalcdep.2009.12.019.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Zaru A, Loi B, Lobina C, Carai MA, Gessa GL, Capra A, Mugnaini C, Pasquini S, Corelli F, et al. Comparison of the effect of the GABAB receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats. Alcohol Clin Exp Res. 2012;36:1748–66. doi:10.1111/j.1530-0277.2012.01782.x.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Vargiolu D, Thomas AW, Malherbe P, Mugnaini C, Corelli F, Leite-Morris KA, Gessa GL, Colombo G. Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen. Psychopharmacology (Berl). 2015;232:1831–41. doi:10.1007/s00213-014-3815-8.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Colombo G, Lorrai I, Zaru A, Carai MAM, Gessa GL, Brizzi A, Mugnaini C, Corelli F. Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors. Psychopharmacology (Berl). 2017;234:2525–43. doi:10.1007/s00213-017-4644-3.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Lorrai I, Contini A, Leite-Morris K, Colombo G. Microinjection of baclofen and CGP7930 into the ventral tegmental area suppresses alcohol self-administration in alcohol-preferring rats. Neuropharmacology. 2018;136:146–58. doi:10.1016/j.neuropharm.2017.10.012.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Fara F, Lorrai I, Acciaro C, Mugnaini C, Corelli F, Colombo G. Suppressing effect of CMPPE, a new positive allosteric modulator of the GABAB receptor, on alcohol self-administration and reinstatement of alcohol seeking in rats. Alcohol. 2019;75:79–87. doi:10.1016/j.alcohol.2018.05.015.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Colombo G, Lorrai I, Fara F, Carai MAM, Gessa GL, Brizzi A, Mugnaini C, Corelli F. Anti-addictive properties of COR659 - additional pharmacological evidence and comparison with a series of novel analogues. Alcohol. 2019;75:55–66. doi:10.1016/j.alcohol.2018.05.007.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Kaczanowska K, Lawrence H, Yun S, Bratzu J, Gessa GL, McDonald P, Colombo G. The novel positive allosteric modulator of the GABAB receptor, KK-92A, suppresses alcohol self-administration and cue-induced reinstatement of alcohol seeking in rats. Front Cell Dev Biol. 2021;9:727576. doi:10.3389/fcell.2021.727576.
   PubMed Web of Science ®Google Scholar
• Augier E, Dulman RS, Damadzic R, Pilling A, Hamilton JP, Heilig M. The GABAB positive allosteric modulator ADX71441 attenuates alcohol self-administration and relapse to alcohol seeking in rats. Neuropsychopharmacology. 2017;42:1789–99. doi:10.1038/npp.2017.53.
   PubMed Web of Science ®Google Scholar
• Lorrai I, Contini A, Gessa GL, Mugnaini C, Corelli F, Colombo G, Maccioni P. Operant, oral alcohol self-administration: sex differences in Sardinian alcohol-preferring rats. Alcohol. 2019;79:147–62. doi:10.1016/j.alcohol.2019.04.003.
   PubMed Web of Science ®Google Scholar
• Haile CN, Carper BA, Nolen TL, Kosten TA. The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats. Psychopharmacology (Berl). 2021;238:2587–600. doi:10.1007/s00213-021-05881-0.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Carai MA, Kaupmann K, Guery S, Froestl W, Leite-Morris KA, Gessa GL, Colombo G. Reduction of alcohol’s reinforcing and motivational properties by the positive allosteric modulator of the GABAB receptor, BHF177, in alcohol-preferring rats. Alcohol Clin Exp Res. 2009;33:1749–56. doi:10.1111/j.1530-0277.2009.01012.x.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Kaczanowska K, McDonald P, Colombo G. Development of partial tolerance to the suppressing effect of the positive allosteric modulator of the GABAB receptor, KK-92A, on alcohol self-administration in rats. Alcohol Alcohol. 2022;in press. doi:10.1093/alcalc/agac026.
   PubMed Web of Science ®Google Scholar
• Kruse LC, Linsenbardt DN, Boehm SL,s2nd. Positive allosteric modulation of the GABAB receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization. Alcohol. 2012;46:455–62. doi:10.1016/j.alcohol.2012.03.004.
   PubMed Web of Science ®Google Scholar
• Maccioni P, Colombo G. Potential of GABAB receptor positive allosteric modulators in the treatment of alcohol use disorder. Cns Drugs. 2019;33:107–23. doi:10.1007/s40263-018-0596-3.
   PubMed Web of Science ®Google Scholar
• Holtyn AF, Weerts EM. Gabab receptors and alcohol use disorders: preclinical studies. Curr Top Behav Neurosci. 2022;52:157–94.
   PubMedGoogle Scholar
• ClinicalTrial.gov. https://clinicaltrials.gov/ct2/show/NCT05096117?term=ASP8062&draw=2&rank=5.
   Google Scholar
• Walzer M, Marek GJ, Wu R, Nagata M, Han D. Single- and multiple-dose safety, tolerability, and pharmacokinetic profiles of ASP8062: results from 2 Phase 1 studies. Clin Pharmacol Drug Dev. 2020;9:297–306. doi:10.1002/cpdd.766.
   PubMed Web of Science ®Google Scholar
• Ito M, Spence A, Blauwet MB, Heo N, Goldwater R, Maruff P, Marek GJ. A phase 1 study to assess potential interaction between asp8062 and alcohol in healthy adult subjects. J Psychopharmacol. 2022;36:2698811211058967. doi:10.1177/02698811211058967.
   Web of Science ®Google Scholar
• Mugnaini C, Pedani V, Casu A, Lobina C, Casti A, Maccioni P, Porcu A, Giunta D, Lamponi S, Solinas M, et al. Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor. J Med Chem. 2013;56:3620–35. doi:10.1021/jm400144w.
   PubMed Web of Science ®Google Scholar
• Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav. 2005;84:53–63. doi:10.1016/j.physbeh.2004.10.007.
   PubMed Web of Science ®Google Scholar
• Colombo G, Lobina C, Carai MA, Gessa GL. Phenotypic characterization of genetically selected Sardinian alcohol-preferring (sP) and -non-preferring (sNP) rats. Addict Biol. 2006;11:324–38. doi:10.1111/j.1369-1600.2006.00031.x.
   PubMed Web of Science ®Google Scholar
• Colombo G, Maccioni P, Acciaro C, Lobina C, Loi B, Zaru A, Carai MA, Gessa GL. Binge drinking in alcohol-preferring sP rats at the end of the nocturnal period. Alcohol. 2014;48:301–11. doi:10.1016/j.alcohol.2014.02.001.
   PubMed Web of Science ®Google Scholar
• Thiele TE, Navarro M. “Drinking in the dark” (DID) procedures: a model of binge-like ethanol drinking in non-dependent mice. Alcohol. 2014;48:235–41. doi:10.1016/j.alcohol.2013.08.005.
   PubMed Web of Science ®Google Scholar
• Malherbe P, Masciadri R, Norcross RD, Knoflach F, Kratzeisen C, Zenner MT, Kolb Y, Marcuz A, Huwyler J, Nakagawa T, et al. Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors. Br J Pharmacol. 2008;154:797–811. doi:10.1038/bjp.2008.135.
   PubMed Web of Science ®Google Scholar
• Urwyler S, Sibley DR. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol Rev. 2011;63:59–126. doi:10.1124/pr.109.002501.
   PubMed Web of Science ®Google Scholar
• Olianas MC, Dedoni S, Onali P. The GABAB positive allosteric modulators CGP7930 and GS39783 stimulate ERK1/2 signalling in cells lacking functional GABAB receptors. Eur J Pharmacol. 2017;794:135–46. doi:10.1016/j.ejphar.2016.11.030.
   PubMed Web of Science ®Google Scholar
• Binet V, Brajon C, Le Corre L, Acher F, Pin JP, Prezeau L. The heptahelical domain of GABAB2 is activated directly by CGP7930, a positive allosteric modulator of the GABAB receptor. J Biol Chem. 2004;279:29085–91. doi:10.1074/jbc.M400930200.
   PubMed Web of Science ®Google Scholar
• Schwartz TW, Holst B. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends Pharmacol Sci. 2007;28:366–73. doi:10.1016/j.tips.2007.06.008.
   PubMed Web of Science ®Google Scholar
• Henderson-Redmond AN, Guindon J, Morgan DJ. Roles for the endocannabinoid system in ethanol-motivated behavior. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:330–39. doi:10.1016/j.pnpbp.2015.06.011.
   PubMed Web of Science ®Google Scholar
• Kunos G. Interactions between alcohol and the endocannabinoid system. Alcohol Clin Exp Res. 2020;44:790–805. doi:10.1111/acer.14306.
   PubMed Web of Science ®Google Scholar
• Colombo G, Orru A, Lai P, Cabras C, Maccioni P, Rubio M, Gessa GL, Carai MA. The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence. Mol Neurobiol. 2007;36:102–12. doi:10.1007/s12035-007-0017-y.
   PubMed Web of Science ®Google Scholar
• Becker JB, Koob GF, Gottesman MM. Sex differences in animal models: focus on addiction. Pharmacol Rev. 2016;68:242–63. doi:10.1124/pr.115.011163.
   PubMed Web of Science ®Google Scholar
• Miller LR, Marks C, Becker JB, Hurn PD, Chen WJ, Woodruff T, McCarthy MM, Sohrabji F, Schiebinger L, Wetherington CL, et al. Considering sex as a biological variable in preclinical research. FASEB J. 2017;31:29–34. doi:10.1096/fj.201600781r.
   PubMed Web of Science ®Google Scholar